| Product Code: ETC13333566 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Non-Invasive Prenatal Diagnostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Non-Invasive Prenatal Diagnostics Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Non-Invasive Prenatal Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Non-Invasive Prenatal Diagnostics Market - Industry Life Cycle |
3.4 Europe Non-Invasive Prenatal Diagnostics Market - Porter's Five Forces |
3.5 Europe Non-Invasive Prenatal Diagnostics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Non-Invasive Prenatal Diagnostics Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 Europe Non-Invasive Prenatal Diagnostics Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.8 Europe Non-Invasive Prenatal Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Europe Non-Invasive Prenatal Diagnostics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 Europe Non-Invasive Prenatal Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Non-Invasive Prenatal Diagnostics Market Trends |
6 Europe Non-Invasive Prenatal Diagnostics Market, 2021 - 2031 |
6.1 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031 |
6.1.3 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Polymerase Chain Reaction, 2021 - 2031 |
6.1.4 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Microarray Analysis, 2021 - 2031 |
6.1.5 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Biochemical Screening, 2020 - 2028 |
6.2 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Down Syndrome Detection, 2021 - 2031 |
6.2.3 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Edwards Syndrome Detection, 2021 - 2031 |
6.2.4 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Patau Syndrome Detection, 2021 - 2031 |
6.2.5 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Turner Syndrome Detection, 2021 - 2031 |
6.3 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Diagnostic Laboratories, 2021 - 2031 |
6.3.4 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Clinical Laboratories, 2021 - 2031 |
6.4 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Instruments, 2021 - 2031 |
6.4.3 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Kits and Reagents, 2021 - 2031 |
6.4.4 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Services, 2020 - 2028 |
7 Europe Non-Invasive Prenatal Diagnostics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.2 Germany Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.3 France Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.4 Poland Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.5 Spain Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.6 Rest of Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.3 Europe Non-Invasive Prenatal Diagnostics Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
7.3.1 United Kingdom (UK) Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.3.2 Germany Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.3.3 France Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.3.4 Poland Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.3.5 Spain Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.3.6 Rest of Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.4 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United Kingdom (UK) Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Germany Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 France Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.4 Poland Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.5 Spain Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.6 Rest of Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.5.1 United Kingdom (UK) Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.5.2 Germany Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.5.3 France Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.5.4 Poland Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.5.5 Spain Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.5.6 Rest of Europe Non-Invasive Prenatal Diagnostics Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8 Europe Non-Invasive Prenatal Diagnostics Market Key Performance Indicators |
9 Europe Non-Invasive Prenatal Diagnostics Market - Export/Import By Countries Assessment |
10 Europe Non-Invasive Prenatal Diagnostics Market - Opportunity Assessment |
10.1 Europe Non-Invasive Prenatal Diagnostics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Non-Invasive Prenatal Diagnostics Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
10.3 Europe Non-Invasive Prenatal Diagnostics Market Opportunity Assessment, By Application Area, 2021 & 2031F |
10.4 Europe Non-Invasive Prenatal Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 Europe Non-Invasive Prenatal Diagnostics Market Opportunity Assessment, By Product Type, 2021 & 2031F |
11 Europe Non-Invasive Prenatal Diagnostics Market - Competitive Landscape |
11.1 Europe Non-Invasive Prenatal Diagnostics Market Revenue Share, By Companies, 2022 |
11.2 Europe Non-Invasive Prenatal Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here